Piceatannol

Peta Jejaring Molekuler

Obat Target Gen Interaksi Enzim Transporter Carrier

Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

1. Pendahuluan & Konsep

Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).

2. Sumber Data (Validasi)

Data Obat: Diekstraksi dari elemen drugbank-id dan name pada skema XML DrugBank.
Target Protein: Diambil dari elemen targets/target yang memuat polipeptida sasaran.
Genetik: Disinkronisasi dari sub-elemen gene-name dan varian snp-effects.
Genetik: Jumlah titik node dibatasi pada maksimal 10 (Slice=10) interaksi untuk menghindari tumpukan data.

3. Algoritma Visualisasi

Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.

4. Legenda Visual

Obat Utama (Pusat Analisis)

Target Protein (Mekanisme)

Gen (Faktor Genetik)

Metode ini mendukung analisis Precision Medicine dan evaluasi risiko Drug-Drug Interaction (DDI).

Profil Farmakokinetik

Waktu Paruh (Half-Life) -

Volume Distribusi -

Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

27 Data

Acetaminophen	The serum concentration of Acetaminophen can be increased when it is combined with Piceatannol.
Propacetamol	The serum concentration of Propacetamol can be increased when it is combined with Piceatannol.
Salmon calcitonin	The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Piceatannol.
Thyrotropin alfa	The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Piceatannol.
Follitropin	The therapeutic efficacy of Follitropin can be decreased when used in combination with Piceatannol.
Liothyronine	The therapeutic efficacy of Liothyronine can be decreased when used in combination with Piceatannol.
Carbimazole	The therapeutic efficacy of Carbimazole can be decreased when used in combination with Piceatannol.
Levothyroxine	The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Piceatannol.
Propylthiouracil	The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Piceatannol.
Methimazole	The therapeutic efficacy of Methimazole can be decreased when used in combination with Piceatannol.
Liotrix	The therapeutic efficacy of Liotrix can be decreased when used in combination with Piceatannol.
3,5-Diiodotyrosine	The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Piceatannol.
Tiratricol	The therapeutic efficacy of Tiratricol can be decreased when used in combination with Piceatannol.
Parathyroid hormone	The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Piceatannol.
Teriparatide	The therapeutic efficacy of Teriparatide can be decreased when used in combination with Piceatannol.
Potassium Iodide	The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Piceatannol.
Dibromotyrosine	The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Piceatannol.
Thyroid, porcine	The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Piceatannol.
Potassium perchlorate	The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Piceatannol.
Protirelin	The therapeutic efficacy of Protirelin can be decreased when used in combination with Piceatannol.
3,5-diiodothyropropionic acid	The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Piceatannol.
Methylthiouracil	The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Piceatannol.
Elcatonin	The therapeutic efficacy of Elcatonin can be decreased when used in combination with Piceatannol.
Benzylthiouracil	The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Piceatannol.
Thyrotropin	The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Piceatannol.
Voriconazole	The serum concentration of Piceatannol can be increased when it is combined with Voriconazole.
Palopegteriparatide	The therapeutic efficacy of Palopegteriparatide can be decreased when used in combination with Piceatannol.

Target Protein

ATP synthase subunit alpha, mitochondrial ATP5F1A

ATP synthase subunit beta, mitochondrial ATP5F1B

ATP synthase subunit gamma, mitochondrial ATP5F1C

Referensi & Sumber

Synthesis reference: Alain Schouteeten, Sebastien Jus, Jean-Claude Vallejos, "Novel Process For The Synthesis Of (E)-Stilbene Derivatives Which Makes It Possible To Obtain Resveratrol And Piceatannol." U.S. Patent US20100004483, issued January 07, 2010.

Contoh Produk & Brand

Produk: 0 • International brands: 0

Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.

Deskripsi

Struktur Molekul 2D

Deskripsi metode visualisasi